Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated significant weight loss results in clinical trials, with patients losing up to 15% of body weight over 68 weeks. Unlike traditional weight loss approaches, semaglutide works by regulating appetite signals in the brain and slowing gastric emptying. Understanding how dosing works is essential for achieving optimal results while managing your treatment plan effectively.
Understanding Semaglutide Dosing Schedules
Semaglutide dosing begins low and increases gradually over 16 to 20 weeks in what clinicians call a titration protocol. This stepped approach allows your body to adapt to the medication while your prescriber monitors your response and tolerability. Most patients start at 0.25 mg weekly, then advance by 0.25 mg increments every four weeks until reaching a therapeutic dose, typically between 1.0 mg and 2.4 mg weekly.
The gradual titration schedule serves a critical purpose: it reduces the intensity of initial side effects like nausea and gastrointestinal discomfort. Research shows that slow dose escalation improves treatment adherence and patient satisfaction compared to faster protocols. PlexusDx works with licensed 503A compounding pharmacies to prepare semaglutide at the exact dose your clinician prescribes during each phase of your titration.
How Your Dose May Increase Over Time
During your first month of treatment, your prescriber will establish a baseline and assess how your body responds to the initial dose. Some patients move through titration steps every four weeks, while others may remain at a maintenance dose longer if they experience significant appetite suppression or gastrointestinal effects. Your clinician will adjust your dose based on your weight loss progress, side effect tolerance, and metabolic markers.
Dose increases are not automatic—they depend entirely on your individual response and clinical goals. Your prescriber may recommend staying at 0.5 mg for six weeks before advancing, or may suggest moving to 1.0 mg sooner if you're tolerating the medication well. PlexusDx supports this personalized approach: your monthly price remains flat regardless of which dose you're prescribed, so your cost never increases as your therapy progresses.
Therapeutic Dose Ranges and Maintenance
Most patients achieve meaningful weight loss results at maintenance doses of 1.0 mg to 2.4 mg administered once weekly by subcutaneous injection. Clinical trials showed that doses above 1.0 mg weekly produced superior weight loss compared to lower doses, with the greatest benefit observed at 2.4 mg weekly. However, not every patient requires the maximum dose; some individuals reach their weight loss goals at 1.0 mg or 1.7 mg and experience optimal tolerability at these levels.
Your prescriber determines your target maintenance dose based on your weight loss trajectory, side effect profile, and overall health goals. Once you reach a dose that produces consistent results and good tolerability, you'll continue that dose weekly while attending regular follow-up appointments to monitor progress. PlexusDx delivers your maintenance-dose semaglutide monthly at the same transparent price, making long-term treatment predictable and affordable.
Genetic Insights for Personalized Semaglutide Response
Individual variation in semaglutide response partly reflects differences in your genetic makeup, particularly genes affecting GLP-1 receptor function and metabolic pathways. The GLP1R rs6923761 variant, for example, influences how effectively your body's GLP-1 receptors respond to the medication, which may affect the dose your clinician selects. Similarly, the GIPR rs1800437 variant relates to glucose-dependent insulinotropic polypeptide signaling, another pathway relevant to semaglutide's mechanism of action.
PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic analysis that maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights related to your weight loss potential and medication response. This test identifies genetic predispositions in pathways like FTO rs9939609 (appetite regulation) and MC4R rs17782313 (energy expenditure) that inform more precise dose targeting and compound selection. Adding genetic testing after your first month of treatment ($99) helps your clinician fine-tune your therapy and understand your individual metabolic blueprint.
Managing Side Effects During Dose Escalation
Nausea is the most common side effect during early semaglutide treatment, affecting 25% to 40% of patients in the first weeks, but typically decreases as your body adapts. Dietary adjustments—eating smaller portions, avoiding fatty or greasy foods, and staying hydrated—significantly reduce nausea severity. Most patients find that side effects diminish substantially within two to four weeks at each dose level, making the gradual titration schedule a practical strategy for long-term success.
If side effects become intolerable, your prescriber may pause your dose escalation or extend the interval between dose increases rather than discontinuing treatment entirely. This flexible approach allows you to achieve therapeutic benefit while maintaining quality of life. Keep detailed notes about how you feel at each dose level and share this information with your clinician at every follow-up visit to ensure your treatment plan remains optimized.
Semaglutide Pricing: Transparent Monthly Cost
PlexusDx compounded semaglutide injection starts at $149 per month, with no additional charges based on your dose or how often you adjust your prescription. This transparent pricing model means you pay the same monthly fee whether you're in your first titration week at 0.25 mg or at a maintenance dose of 2.4 mg—your dose may need to go up, but your price won't. HSA and FSA accounts are eligible for use with PlexusDx medications, adding another layer of affordability for qualified patients.
No insurance is required, and there are no hidden membership fees or surprise charges when you increase your dose. PlexusDx serves all 50 states through licensed 503A compounding pharmacies, ensuring your medication is prepared under strict quality standards. Your monthly subscription includes prescription management support and coordination with your prescriber to keep your treatment on track.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once per week. Your clinician increases this dose by 0.25 mg every four weeks until reaching your target maintenance dose, typically between 1.0 mg and 2.4 mg weekly, depending on your individual response and tolerability.
How long does the titration schedule last before I reach my final dose?
Most patients complete the full titration schedule in 16 to 20 weeks, moving through five or six dose increments. However, your prescriber may adjust this timeline based on your side effect experience and weight loss progress; some patients stay at each dose level longer if needed for comfort or clinical reasons.
Will my PlexusDx monthly cost increase if my dose goes up?
No. PlexusDx compounded semaglutide injection is priced at $149 per month flat, regardless of your current dose or any future dose adjustments. Your dose may increase as your treatment progresses, but your monthly price remains the same.
What happens if I experience severe nausea during dose escalation?
Contact your prescriber immediately to discuss your symptoms. Your clinician may recommend dietary changes, extend the time between dose increases, or adjust your treatment plan while keeping you on therapy. Most patients find nausea improves after two to four weeks at each dose level as their body adapts.
How can the Precision Peptide Genetic Test help with my semaglutide dosing?
PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions in GLP-1 receptor pathways (GLP1R rs6923761), glucose signaling (GIPR rs1800437), and appetite regulation (FTO rs9939609), helping your clinician select a more precise dose strategy and predict your likely response to therapy. This $99 add-on test after your first month provides 150+ personalized insights across 14 metabolic pathways.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will Ozempic Help Me If I Weigh 200 Pounds? Realistic Results and Timelines
Is It OK to Inject Ozempic Cold? Understanding Proper Storage and Usage Guidelines